How Is The Market Feeling About Krystal Biotech?
Portfolio Pulse from Benzinga Insights
Krystal Biotech's short interest has decreased by 4.6%, with 16.18% of its float sold short. This is higher than its peers' average of 11.66%. The decrease in short interest may indicate a shift in market sentiment.
September 10, 2024 | 4:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Krystal Biotech's short interest has decreased by 4.6%, now at 16.18% of float, which is higher than its peers' average. This decrease may suggest a shift towards a more bullish sentiment.
The decrease in short interest suggests that fewer investors are betting against Krystal Biotech, which could indicate a more positive market sentiment. This is significant as the short interest is still higher than its peers, suggesting potential for a short squeeze if sentiment continues to improve.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100